CHENGDU, China, Sept. 30 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co. Inc. (NYSE Amex: TPI), a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today announced that it will present at the Roth China Conference, to be held October 12-14, 2009, at Fontainebleau Miami Beach, FL.
Mr. Stewart Lor, Director, is scheduled to present at 12:30 pm ET on Wednesday, October 14th, 2009 and participate in one-on-one meetings with conference attendees throughout the three-day event. The presentation will discuss the Company's diversified product portfolio, customer base addressable market, competitive landscape, and recent financial results. Mr. Lor will provide additional details on the $126 billion government sponsored healthcare reform plan and its potential benefits to the Company's long-term growth strategy.
Registration is by invitation and registration is mandatory. For more information on the conference, contact your Roth representative or visit http://www.roth.com .
About ROTH Capital Partners
ROTH is a full service investment banking firm dedicated to the small and micro-cap market. The firm is privately owned with current principals being majority owners. The core management team has been consistent for many years. Since the inception of the firm in 1984, ROTH has been a leader and innovator in the small and micro cap markets. Roth's exclusive focus has been, is, and will continue to offer a full spectrum of investment banking services, including raising capital, research coverage, trading and market making, merger and acquisition advisory services, and investor conferences.
About Tianyin Pharmaceuticals
Tianyin is a manufacturer and
|SOURCE Tianyin Pharmaceutical Co. Inc.|
Copyright©2009 PR Newswire.
All rights reserved